KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Total Current Liabilities (2016 - 2025)

Chemed (CHE) has 17 years of Total Current Liabilities data on record, last reported at $287.1 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 0.5% year-over-year to $287.1 million; the TTM value through Dec 2025 reached $287.1 million, up 0.5%, while the annual FY2025 figure was $287.1 million, 0.5% up from the prior year.
  • Total Current Liabilities reached $287.1 million in Q4 2025 per CHE's latest filing, down from $292.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $312.0 million in Q4 2023 and bottomed at $261.8 million in Q2 2024.
  • Average Total Current Liabilities over 5 years is $286.5 million, with a median of $286.6 million recorded in 2021.
  • The widest YoY moves for Total Current Liabilities: up 17.62% in 2021, down 16.05% in 2021.
  • A 5-year view of Total Current Liabilities shows it stood at $302.4 million in 2021, then fell by 1.72% to $297.2 million in 2022, then grew by 4.99% to $312.0 million in 2023, then decreased by 8.45% to $285.7 million in 2024, then grew by 0.5% to $287.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $287.1 million in Q4 2025, $292.0 million in Q3 2025, and $263.9 million in Q2 2025.